M2 MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
M2 MEDICAL
Largest movements
- Cash +€54,484
up €54,484 (+1,816%), from €3,000 to €57,484
mainly Net result for the year (+€72,592) and Other debts (+€10,712)
- Tangible fixed assets +€18,262
new in 2025: €18,262
- Current investments +€10,000
new in 2025: €10,000
- Deferred charges and accrued income +€8,264
up €8,264 (+37.1%), from €22,249 to €30,513
- Profit (loss) carried forward +€72,592
up €72,592 (+474%), from €15,327 to €87,918
- Other debts +€10,712
up €10,712 (+419%), from €2,557 to €13,269
- Tax, wage and social debts +€5,226
up €5,226 (+136%), from €3,832 to €9,057
- Trade debts +€2,481
up €2,481 (+464%), from €534 to €3,015
- Gross operating margin +€76,740
up €76,740 (+401%), from €19,158 to €95,898
- Taxes +€15,226
up €15,226 (+397%), from €3,832 to €19,057
- Depreciation +€3,222
new in 2025: €3,222
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €25,249 | €116,260 | +€91,011 | +360% |
| Fixed assets | 21/28 | - | €18,262 | +€18,262 | |
| Tangible fixed assets | 22/27 | - | €18,262 | +€18,262 | |
| Furniture and vehicles | 24 | - | €18,262 | +€18,262 | |
| Current assets | 29/58 | €25,249 | €97,997 | +€72,748 | +288% |
| Current investments | 50/53 | - | €10,000 | +€10,000 | |
| Cash at bank and in hand | 54/58 | €3,000 | €57,484 | +€54,484 | +1,816% |
| Deferred charges and accrued income | 490/1 | €22,249 | €30,513 | +€8,264 | +37.1% |
| Total equity and liabilities | 10/49 | €25,249 | €116,260 | +€91,011 | +360% |
| Equity | 10/15 | €18,327 | €90,918 | +€72,592 | +396% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €15,327 | €87,918 | +€72,592 | +474% |
| Amounts payable | 17/49 | €6,923 | €25,341 | +€18,419 | +266% |
| Amounts payable within one year | 42/48 | €6,923 | €25,341 | +€18,419 | +266% |
| Trade debts | 44 | €534 | €3,015 | +€2,481 | +464% |
| Suppliers | 440/4 | €534 | €3,015 | +€2,481 | +464% |
| Taxes, remuneration and social security | 45 | €3,832 | €9,057 | +€5,226 | +136% |
| Taxes | 450/3 | €3,832 | €9,057 | +€5,226 | +136% |
| Other amounts payable | 47/48 | €2,557 | €13,269 | +€10,712 | +419% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €3,222 | +€3,222 | |
| Other operating charges | 640/8 | - | €941 | +€941 | |
| Gross operating margin | 9900 | €19,158 | €95,898 | +€76,740 | +401% |
| Operating profit (loss) | 9901 | €19,158 | €91,735 | +€72,576 | +379% |
| Financial charges | 65/66B | - | €85 | +€85 | |
| Recurring financial charges | 65 | - | €85 | +€85 | |
| Profit (loss) for the period before taxes | 9903 | €19,158 | €91,649 | +€72,491 | +378% |
| Income taxes | 67/77 | €3,832 | €19,057 | +€15,226 | +397% |
| Profit (loss) for the period | 9904 | €15,327 | €72,592 | +€57,265 | +374% |
| Profit (loss) for the period to be appropriated | 9905 | €15,327 | €72,592 | +€57,265 | +374% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.